
    
      Safety study in patients with schizophrenia who have participated and completed a study
      investigating Lu AF35700 including Studies 16159A and 16323A. Or in patients with
      schizophrenia for whom a switch of antipsychotic treatment can be potentially beneficial
      according to the investigator's clinical judgement.
    
  